Articles dans des revues avec comité de lecture (103)

  1. 85. Voorzanger-Rousselot, N., Goehrig, D., Journé, F., Doriath, V., Body, J.-J., Clezardin, P., & Garnero, P. (2007). Increased Dickkopf-1 expression in breast cancer bone metastases. British Journal of Cancer, 97(7), 964-970. doi:10.1038/sj.bjc.6603959
  2. 86. Nonclercq, D., Journé, F., Laïos, I., Chaboteaux, C., Toillon, R.-A., Leclercq, G., & Laurent, G. (2007). Effect of nuclear export inhibition on estrogen receptor regulation in breast cancer cells. Journal of molecular endocrinology, 39(1-2), 105-118. doi:10.1677/JME-07-0040
  3. 87. Saussez, S., Lorfevre, F., Nonclercq, D., Laurent, G., André, S., Journé, F., Kiss, R., Toubeau, G., & Gabius, H.-J. (2006). Towards functional glycomics by localization of binding sites for tissue lectins: lectin histochemical reactivity for galectins during diethylstilbestrol-induced kidney tumorigenesis in male Syrian hamster. Histochemistry and cell biology, 126(1), 57-69. doi:10.1007/s00418-006-0146-9
  4. 88. Debauve, G., Nonclercq, D., Ribaucour, F., Wiedig, M., Gerbaux, C., Leo, O., Laurent, G., Journé, F., Belayew, A., & Toubeau, G. (2006). Early expression of the Helicase-Like Transcription Factor (HLTF/SMARCA3) in an experimental model of estrogen-induced renal carcinogenesis. Molecular cancer, 5, 23. doi:10.1186/1476-4598-5-23
  5. 89. Journé, F., Magne, N., Chaboteaux, C., Kinnaert, E., Bauss, F., & Body, J.-J. (2006). Sequence- and concentration-dependent effects of acute and long-term exposure to the bisphosphonate ibandronate in combination with single and multiple fractions of ionising radiation doses in human breast cancer cell lines. Clinical & experimental metastasis, 23(2), 135-147. doi:10.1007/s10585-006-9025-y
  6. 90. Journé, F., Chaboteaux, C., Magne, N., Duvillier, H., Laurent, G., & Body, J.-J. (2005). Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines. Breast cancer research, 8(1), R2. doi:10.1186/bcr1363
  7. 91. Laïos, I., Journé, F., Nonclercq, D., Vidal, D. S., Toillon, R.-A., Laurent, G., & Leclercq, G. (2005). Role of the proteasome in the regulation of estrogen receptor α turnover and function in MCF-7 breast carcinoma cells. Journal of steroid biochemistry and molecular biology, 94(4), 347-359. doi:10.1016/j.jsbmb.2005.02.005
  8. 92. Journé, F., Chaboteaux, C., Dumon, J. C., Leclercq, G., Laurent, G., & Body, J.-J. (2004). Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells. British Journal of Cancer, 91(9), 1703-1710. doi:10.1038/sj.bjc.6602181
  9. 93. Nonclercq, D., Journé, F., Body, J.-J., Leclercq, G., & Laurent, G. (2004). Ligand-independent and agonist-mediated degradation of estrogen receptor-α in breast carcinoma cells: Evidence for distinct degradative pathways. Molecular and cellular endocrinology, 227(1-2), 53-65. doi:10.1016/j.mce.2004.07.003
  10. 94. Journé, F., Dumon, J. C., Kheddoumi, N., Fox, J. J., Laïos, I., Leclercq, G., & Body, J.-J. (2004). Extracellular calcium downregulates estrogen receptor alpha and increases its transcriptional activity through calcium-sensing receptor in breast cancer cells. Bone, 35(2), 479-488. doi:10.1016/j.bone.2004.03.021
  11. 95. Journé, F., Body, J.-J., Leclercq, G., Nonclercq, D., & Laurent, G. (2004). Estrogen responsiveness of IBEP-2, a new human cell line derived from breast carcinoma. Breast cancer research and treatment, 86(1), 39-53. doi:10.1023/B:BREA.0000032922.87541.31
  12. 96. Dumon, J. C., Journé, F., Kheddoumi, N., Lagneaux, L., & Body, J.-J. (2004). Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells. European urology, 45(4), 521-8; discussion 528-9. doi:10.1016/j.eururo.2003.12.012

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>